Abstract
Summary
Anti-staphylococcal ^-hemolysin levels in patients with multiple sclerosis and other diseases and in controls were studied. Statistically significant differences in titers were found between the neurologic disease group and MS patients, and between the staphylococcal infected group and MS patients. Possible explanation for these differences are presented.
Get full access to this article
View all access options for this article.